Dr Courtney Davis
Dr Courtney Davis is a medical and political sociologist with broad research interests in the intersections of science and technology policy, business regulation and public health. She undertakes empirically-based, international comparative research investigating the socio-political, economic, cultural and scientific factors underlying trends in regulation and the implications of current techno-scientific standards for public, patient and worker health, with a particular focus on pharmaceuticals and occupational health and safety.
Courtney is currently investigating the relationship between regulatory standards for pharmaceutical marketing approval and the evidential needs of health technology assessment bodies and healthcare systems as part of a 2-year ESRC Mid-Career Development Fellowship. She is also involved in a number of collaborative research projects with colleagues from the Institute of Cancer Policy, King’s College London; the University of Southampton’s Business Scholl and the International Institute for the Study of Cuba; and the School of Population and Public Health at the University of British Columbia.
Past research projects
Between 2008 and 2012 Courtney received funding from the Wellcome Trust to investigate cancer patient advocates’ attitudes towards, and engagement with, innovative drug development and regulatory science in the United States, the United Kingdom and at the pan-European level. This research followed her work on three large, ESRC-funded research projects investigating the regulation of drug safety, efficacy and innovation in the UK, the US and the supranational EU with Professor John Abraham. Taken together, these projects constitute a body of international comparative research on pharmaceuticals regulation that spans the entire period of modern drug regulation in these regions. Her work on drug safety withdrawals has achieved international recognition and was reviewed by the Institute of Medicine of the National Academies of Science in the United States during its ongoing investigation and assessment of current systems for ensuring drug safety post-marketing in the US. Courtney has also undertaken research on trends in the enforcement of occupational health and safety in the UK and internationally, and has been commissioned to undertake research for government bodies, trade unions and NGOs. In 2004 she was invited to appear as a witness before the Parliamentary Select Committee inquiry into the work of the Health and Safety Executive and Commission, and in 2011 was invited to contribute to a Department of Work and Pensions Review of occupational health and safety legislation (the ‘Lofstedt Review’).
Impact and Engagement
She has been interviewed and consulted by journalists from The Lancet, The Guardian, Panorama, and most recently for the BBC’s File on 4 programme. As well as receiving invitations to present her research to national and international academic audiences, she has been invited to present to a range of government, professional, industry and third sector audiences, both within the UK and overseas – including the Health and Safety Commission, the Institution for Occupational Safety and Health (IOSH), Health Technology Assessment International (HTAi), GlaxoSmithKline, the Trades Union Congress, Health Action International, and the UK Hazards movement.
Between 2003 and 2007 Courtney served as a Board Member, then as Deputy Director of the Centre for Corporate Accountability. She is a member of Health Action International (HAI) and represented HAI at a WHO meeting on patient and citizen involvement in research priority setting in Brussels in February 2013.
Her book Unhealthy Pharmaceutical Regulation: Innovation, Politics and Promissory Science, with John Abraham, was published by Palgrave in 2013.
Tel: +44 (0)20 7848 2720